Barth Syndrome
Oncology·MeSH: Barth Syndrome
Prevalence
0.5 / 100K
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Phase 4(1)
| Drug | Company |
|---|---|
| elamipretide | SAB BIOTHERAPEUTICS, INC. (SABS) |
Frequently asked questions
How many drugs are in development for Barth Syndrome?
BioSniper tracks 2 drugs in development for Barth Syndrome across 2 companies.
How many clinical trials target Barth Syndrome?
There are 2 clinical trials targeting Barth Syndrome tracked by BioSniper.
What is the prevalence of Barth Syndrome?
The estimated prevalence of Barth Syndrome is approximately 0.5 per 100,000 population.
Deep-dive into Barth Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis